Mechanism of Trichosanthis Pericarpium Aqueous Extract in Protecting H9c2 Cardiomyocytes from Hypoxia/Reoxygenation Injury via PI3K/Akt/NO Signaling Pathway
Pharmacology|更新时间:2021-02-09
|
Mechanism of Trichosanthis Pericarpium Aqueous Extract in Protecting H9c2 Cardiomyocytes from Hypoxia/Reoxygenation Injury via PI3K/Akt/NO Signaling Pathway
Chinese Journal of Experimental Traditional Medical FormulaeVol. 25, Issue 22, Pages: 42-48(2019)
Dong-hai CHU, Zhen-qiu ZHANG. Mechanism of Trichosanthis Pericarpium Aqueous Extract in Protecting H9c2 Cardiomyocytes from Hypoxia/Reoxygenation Injury via PI3K/Akt/NO Signaling Pathway. [J]. Chinese Journal of Experimental Traditional Medical Formulae 25(22):42-48(2019)
DOI:
Dong-hai CHU, Zhen-qiu ZHANG. Mechanism of Trichosanthis Pericarpium Aqueous Extract in Protecting H9c2 Cardiomyocytes from Hypoxia/Reoxygenation Injury via PI3K/Akt/NO Signaling Pathway. [J]. Chinese Journal of Experimental Traditional Medical Formulae 25(22):42-48(2019) DOI: 10.13422/j.cnki.syfjx.20192104.
Mechanism of Trichosanthis Pericarpium Aqueous Extract in Protecting H9c2 Cardiomyocytes from Hypoxia/Reoxygenation Injury via PI3K/Akt/NO Signaling Pathway
To investigate the effect of Trichosanthis Pericarpium aqueous extract(TPAE)in protecting H9c2 cells from hypoxia/reoxygenation (H/R) injury by activating phosphatidylionsitol-3-kinase/protein kinase B/nitric oxide(PI3K/Akt/NO) signaling pathway.
Method:
2
The 2.5 mmol·L
-1
Na
2
S
2
O
4
was used to induce the model of H9c2 cardiomyocytes H/R injury in the experiments. The cultured H9c2 cardiomyocytes were randomly divided into normal group
H/R group (model group) and inhibition group (LY294002
10 μmol·L
-1
). In the H/R + TPAE group
50 mg·L
-1
TPAE was added to the cultures at 24 h before H/R exposure. Cell viability was measured by methyl thiazolyl tetrazolium (MTT) assay. The amounts of NO
endothelial nitric oxide synthase (eNOS)
and induced nitric oxide synthase (iNOS) were tested by enzyme linked immunosorbent assay (ELISA) kits. Reverse transcription-quantitative real-time polymerase chain reaction (Real-time PCR) was performed to analyze relative mRNA expressions of Akt
eNOS and iNOS. Western blot was used to detect the expressions of Akt
p-Akt (Ser 473)
eNOS
and iNOS.
Result:
2
Compared with the normal control group
the cell viability significantly decreased in the model control group (
P
<
0.01)
the release of NO was obviously down-regulated (
P
<
0.01)
the mRNA and protein expressions of p-Akt
Akt
eNOS were remarkably decreased (
P
<
0.01)
while those of iNOS were up-regulated (
P
<
0.01). Compared with the H/R group
the pretreatment with TPAE remarkably improved the morphological lesion of cardiomyocytes
enhanced cell viability(
P
<
0.01)
increased the expressions of Akt
p-Akt (Ser 473) and eNOS(
P
<
0.01)
decreased the expression of iNOS(
P
<
0.01)
and increased the release of NO(
P
<
0.01). The PI3K inhibitor LY294002 was used. Obviously
cardioprotection of Trichosanthis Pericarpium aqueous extract was blocked by co-treatment LY294002
and cell viability was correspondingly reversed.
Conclusion:
2
TPAE can protect H9c2 cardiomyocytes from H/R injury by activating PI3K/Akt signaling pathway
which might be related to the up-regulation of the mRNA and protein expressions of eNOS
the down-regulation of the level of iNOS
and the increase of the production of physiological amounts of NO.